A novel heterozygous mutation in the NOTCH3 gene causing CADASIL

Swiss Medical Weekly

Volumn 138, Issue 41-42, 2008, Pages 614-617

  Andreadou, Elisabeth ^a   Papadimas, George ^a   Sfagos, Constantinos ^a  

^a NATIONAL AND KAPODISTRIAN UNIVERSITY OF ATHENS   (Greece)

Author keywords

CADASIL; Mutations; NOTCH3 gene; Stroke

Indexed keywords

GADOLINIUM; HEXAMETHYLPROPYLENE AMINE OXIME TECHNETIUM TC 99M; NOTCH3 RECEPTOR;

ADULT; ARTICLE; ATTENTION DEFICIT DISORDER; BRAIN DAMAGE; CADASIL; CASE REPORT; CAUDATE NUCLEUS; CEREBROSPINAL FLUID ANALYSIS; DEATH; DEMENTIA; DIAGNOSTIC ERROR; DISEASE COURSE; EXON; FAMILY HISTORY; GENE; GENE MUTATION; HEMISPHERE; HUMAN; HYPOTHALAMUS PERIVENTRICULAR NUCLEUS; MALE; MULTIPLE SCLEROSIS; NEUROIMAGING; NEUROPSYCHOLOGICAL TEST; NOTCH3 RECEPTOR GENE; NUCLEAR MAGNETIC RESONANCE IMAGING; OCCIPITAL LOBE; SIBLING; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; TEMPORAL LOBE; TRANSIENT ISCHEMIC ATTACK; WHITE MATTER;

EID: 54349119245     PISSN: 14247860     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Davous P. CADASIL: a review with proposed diagnostic criteria. Eur J Neurol. 1998;5:219-33.
2. Monet M, Domenga V, Lemaire B, Souilhol C, Langa F, Babinet C, et al. The archetypal R90C CADASIL NOTCH3 mutation retains NOTCH3 function in vivo. Hum Mol Genet. 2007;16(8):982-92.
3. Razvi SS, Bone I. Single gene disorders causing ischaemic stroke. J Neurol. 2006;253(6):685-700.
4. Arima K, Yanagawa S, Ito N, Ikeda S. Cerebral arterial pathology of CADASIL and CARASIL (Maeda syndrome). Neuropathology. 2003;23(4):327-34.
5. Hofmann JJ, Iruela-Arispe ML. Notch signalling in blood vessels. Who is talking to whom about what? Circ Res. 2007;100:1556-68.
6. Federico A, Bianchi S, Dotti MT. The spectrum of mutations for CADASIL diagnosis. The spectrum of mutations for CADASIL diagnosis. Neurol Sci. 2005;26:117-24.
7. Mandellos D, Limbitaki G, Papadimitriou A, Anastasopoulos D. Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) in Greek family. Neurol Sci. 2005;26:278-81.
8. Vikelis M, Papatriantafyllou J, Karageorgiou K. A novel CADASIL-causing mutation in a stroke patient. Swiss Med Wkly. 2007;137:323-5.
9. Escary JL, Cécillon M, Maciazec J, Lathrop M, Tournier-Lasserve E, Joutel A. Evaluation of DHPLC analysis in mutational scanning of Notch3, a gene with a high G-C content. Hum Mutat. 2000;16:518-26.
10. Lesnik Oberstein SA, van Duinen SG, van den Boom R, Maat-Schieman ML, van Buchem MA, van Houwelingen HC, et al. Evaluation of diagnostic NOTCH3 immunostaining in CADASIL. Acta Neuropathol. 2003;106:107-11.
11. Kim Y, Choi EJ, Choi CG, Kim G, Choi JH, Yoo HW, et al. Characteristics of CADASIL in Korea. A novel cysteine-sparing Notch3 mutation. Neurology. 2006; 66:1511-6.
12. O'Sullivan M, Jarosz JM, Martin RJ, Deasy N, Powell JF, Markus HS. MRI hyperintensities of the temporal lobe and external capsule in patients with CADASIL. Neurology. 2001;56:628-34.
13. Choi JC, Kang SY, Kang JH, Park JK. Intracerebral hemorrhages in CADASIL. Neurology. 2006;67:2042-4.
14. Maclean AV, Woods R, Alderson LM, Salloway SP, Correia S, Cortez S, et al. Spontaneous lobar hemorrhage in CADASIL. J Neurol Neurosurg Psychiatry. 2005;76:456-7.
15. Milunsky A, Konialis C, Shim SH, Maher TA, Spengos K, Ito M, et al. The prenatal diagnosis of cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) by mutation analysis. Prenat Diagn. 2005;25:1057-8.